Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.1110
-0.0120 (-9.76%)
Mar 4, 2026, 9:30 AM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $17.43 million as of March 5, 2026. Its market cap has decreased by -22.06% in one year.
Market Cap
17.43M
Enterprise Value
14.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.11
Market Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has increased from 14.08M to 17.43M, an increase of 23.83%. That is a compound annual growth rate of 0.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 19.15M | 146.56% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 37.00M |
| Harvard Apparatus Regenerative Technology | 30.24M |
| Finch Therapeutics Group | 21.28M |
| Provectus Biopharmaceuticals | 20.59M |
| EOM Pharmaceuticals Holdings | 20.24M |
| Oncotelic Therapeutics | 19.26M |
| Zenith Capital | 19.17M |
| Anebulo Pharmaceuticals | 16.30M |